Skip to main content
. Author manuscript; available in PMC: 2014 Mar 27.
Published in final edited form as: J Med Chem. 2012 Oct 31;55(22):9973–9987. doi: 10.1021/jm301212u

Table 1.

Radioligand Competition Binding Affinity(Ki)Data of PAM Derivatives

graphic file with name nihms562666t1.jpg
compd R1 R2 MW cLogP Ki (CB2), nMa,b Ki (CB1, nMa,c SId
9 H p-(CH3)2N- 401.50 4.04 777 >20000 >26
11 H H- 358.43 3.93 9930 NT
12 H o-F- 376.42 4.08 35330 NT
13 H m-F- 376.42 4.08 12670 NT
14 H p-F- 376.42 4.08 10900 NT
15 H p-Cl- 392.88 4.54 3081 NT
16 H p-Br- 437.33 4.70 2226 NT
17 H p-CH3- 372.46 4.45 494 109
18 H p-i-C3H7- 400.51 5.18 85 >20000 >235
19 H p-CH3O- 388.46 3.78 783 >20000 >26
20 H p-C2HsO- 402.49 4.13 1500 NT
21 H p-i-C3H7O- 416.51 4.55 313 >20000 >64
22 H o-CF3- 426.43 4.81 11780 NT
23 H p-CF3- 426.43 4.81 596 >20000 >34
24 H p-NO2 403.43 3.87 NB NT
25 H p-H2N- 373.45 2.51 12550 NT
26 H p-(C2H5)2N- 429.55 4.76 64 >20000 >313
27 H p-(C3H7)2N- 457.61 5.80 22 >20000 >909
28 H p-(C4H9)2N- 485.66 6.69 221 >20000 >90
29 H p-(benzyl)2N- 553.69 7.33 203 >20000 >99
30 H p-pyrrolidinyl- 427.53 4.45 71 >20000 >281
31 H p-piperidyl- 441.56 4.89 595 >20000 >34
32 Cl H- 427.32 5.14 NB NT
33 Cl o-F- 445.31 5.29 10850 NT
34 Cl p-F- 445.31 5.29 NB NT
35 Cl p-Cl- 461.77 5.75 154 >20000 >130
36 Cl p-CH3- 441.35 5.66 462 >20000 >43
37 Cl p-CH3O- 457.35 4.98 310 >20000 >65
38 Cl o-CF3- 495.32 6.02 158 >20000 >127
39 Cl p-CF3- 495.32 6.02 101 >20000 >198
40 Cl p-NO2- 472.32 5.08 NB NT
41 CF3 H- 494.43 5.69 NB NT
42 CF3 o-F- 512.42 5.83 NB NT
43 CF3 p-F- 512.42 5.83 NB NT
44 CF3 p-Cl- 528.87 6.29 NB NT
45 CF3 p-CH3- 508.46 6.20 NB NT
46 CF3 p-CH3O- 524.45 5.53 NB NT
47 CF3 p-CF3- 562.43 6.57 NB NT
1e,f 2.1 NT
10e,g NT 10.6
a

Binding affinities of compounds for CB1 and CB2 receptor were evaluated using [3H]CP-55,940 radioligand competition binding assay.

b

NB: no binding, Ki > 20000 nM.

C

NT: not tested.

d

SI: selectivity index for CB2, calculated as Ki(CB1)/Ki(CB2) ratio.

e

The binding affinities of reference compounds were evaluated in parallel with compounds 9, 11–61 under the same conditions.

f

CB2 reference compound SR144528.

g

CB1 reference compound SR141716.